Skip to main content

Table 1 Main characteristics of included studies

From: Economic impact of HIV/AIDS: a systematic review in five European countries

Country Author Publication year Journal Sample size Focus (according papers’ authors) Focus (according reviewers) Costs approximation (according papers’ authors) Costs approximation (according reviewers)
Spain Domingo JM et al. 1998 Oficial Journal Of The International AIDS Society 249 No information Prevalence No information Bottom-up
Spain Velasco M et al. 2000 HIV Medicine 155 No information Prevalence No information Bottom-up
Spain Mompó C et al. 2000 Gaceta Sanitaria 109 No information Prevalence No information Bottom-up
Spain Llibre-Codina JM et al. 2007 Enfermedades Infecciosas y Microbiologia Clínica 1.286 Prevalence Prevalence No information Bottom-up
Spain Velasco M et al. 2007 European Journal Of Internal Medicine 101 No information Prevalence No information Bottom-up
Spain Santolaya Perrín et al. 2008 The Annals Of Pharmacotherapy 144 No information Prevalence No information Bottom-up
Spain Lopez-Bastida et al. 2009 BIOMEDCENTRAL Health Services Research 572 Prevalence Prevalence Bottom-up Bottom-up
Germany Stoll M et al. 2002 Journal of Medical Research 168 (average 3 years) No information Prevalence No information Bottom-up
France Mouton Y et al. 1997 Oficial Journal Of The International AIDS Society 7.749 No information Prevalence No information Bottom-up
France Rahmouni S et al. 1998 International Society For Pharmacoeconomics And Outcomes Research 1.558 No information Prevalence No information Bottom-up
France Peyron F et al. 1999 The Journal Of Pharmacy Technology 257 No information Prevalence No information Bottom-up
France Le Pen C et al. 2001 HIV Clinical Trials 500 No information Prevalence No information Bottom-up
France Yazdapnpanah Y et al. 2002 Antirretroviral Therapy 1.232 No information Prevalence Micro-costing Bottom-up
Italy Floridia M et al. 2000 HIV Clinical Trials 166 Incidence Incidence No information Bottom-up
Italy Garattini L et al. 2001 AIDS Care 483 No information Prevalence Micro-costing Bottom-up
Italy Sabbatini S, Cesari R. 2002 Clinical Drug Investigation 650 No information Prevalence No information Bottom-up
Italy Torti C et al. 2003 Health Policy 1.268 (average 4 years) No information Prevalence No information Bottom-up
Italy Tramarin A et al. 2004 Pharmacoeconomics 74 No information Prevalence No information Bottom-up
Italy Merito M et al. 2005 Health Policy 5.422 No information Prevalence No information Bottom-up
Italy Hubben GAA et al. 2008 AIDS Care 119 Prevalence Prevalence Bottom-up Bottom-up
United Kingdom Beck EJ et al. 1998 Pharmacoeconomics 5.783 No information Prevalence Specific hospital activity related to specific hospital unit costs Bottom-up
United Kingdom NPMS Steering Group. 1998 International Journal Of STD & AIDS 6.002 Prevalence Prevalence No information Bottom-up
United Kingdom Beck EJ, Tolley K. 1998 International Journal Of STD & AIDS 5.708 Prevalence Prevalence No information Bottom-up
United Kingdom Sculpher MJ et al. 1998 Oficial Journal Of The International AIDS Society No information No information Incidence No information Bottom-up
United Kingdom Mullins CD et al. 2000 Clinical Therapeutics 4.817 No information Prevalence No information Bottom-up
United Kingdom Evans HER et al. 2009 Sexually Transmitted Infections 2.189 No information Prevalence No information Bottom-up